Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Currently submitted to: JMIR Research Protocols

Date Submitted: Feb 3, 2024

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Co-production and policy in social prescribing initiatives: protocol for a scoping review

  • Madeline Dougherty; 
  • Tamara Tompkins; 
  • Elaine Zibrowski; 
  • Jesse Cram; 
  • Maureen C Ashe; 
  • Le-Tien Bhaskar; 
  • Kiffer Card; 
  • Christina Godfrey; 
  • Paul Hebert; 
  • Ron Lacombe; 
  • Caitlin Muhl; 
  • Kate Mulligan; 
  • Gillian Mulvale; 
  • Michelle Nelson; 
  • Myrna Norman; 
  • Bobbi Symes; 
  • Gary Teare; 
  • Vivian Welch; 
  • Anita Kothari

ABSTRACT

Background:

Social Prescribing (SP) takes a holistic approach to health by linking clients from the clinical setting to community programs to address their non-medical needs. The emerging, SP evidence base demonstrates variability in how different SP initiatives are designed and implemented. To effectively address these needs, co-production between clients, communities, stakeholders and policy makers is important to tailor social prescribing initiatives for optimal uptake.

Objective:

The objective of this scoping review is to explore the role of coproduction and policy on social prescribing initiatives. This objective will be addressed by the following research questions: 1) How has co-production been incorporated into SP across a range of SP initiatives, and 2) How has policy potentially influenced, as a facilitator or barrier, SP initiatives?

Methods:

A review of international literature will be conducted using the JBI guideline for scoping reviews. Multiple databased including Scopus, Medline, and the PAIS Index will be searched along with grey literature disseminated during 2000-2023. Primary studies for inclusion will describe: a non-medical need for the client, non-medical SP program or initiative, co-production of the SP program and follow up. Review articles and commentaries will be excluded. Titles, abstracts, and full text articles will be screened, and data extracted by at least two team members using Covidence and a pilot-tested extraction template. Clients with lived experience will be included in the research process. Findings will be descriptively summarized and thematically synthesized to answer the two research questions. This scoping review has been registered with Open Science Framework.

Results:

The project was funded in 2022, the results are expected to be submitted for publication in late 2024.

Conclusions:

This scoping review will address the knowledge gap on how co-production is used in SP initiatives and how policy influences those initiatives. We anticipate this review will be used to guide clients, communities, stakeholders and policy makers to further develop SP practice and policy options in healthcare systems.


 Citation

Please cite as:

Dougherty M, Tompkins T, Zibrowski E, Cram J, Ashe MC, Bhaskar LT, Card K, Godfrey C, Hebert P, Lacombe R, Muhl C, Mulligan K, Mulvale G, Nelson M, Norman M, Symes B, Teare G, Welch V, Kothari A

Co-production and policy in social prescribing initiatives: protocol for a scoping review

JMIR Preprints. 03/02/2024:57062

DOI: 10.2196/preprints.57062

URL: https://preprints.jmir.org/preprint/57062

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.

Advertisement